{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:21:43Z","timestamp":1794849703815,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection in Wuhan, China has posed a serious threat to global public health. To develop specific anti-coronavirus therapeutics and prophylactics, the molecular mechanism that underlies viral infection must first be defined. Therefore, we herein established a SARS-CoV-2 spike (S) protein-mediated cell\u2013cell fusion assay and found that SARS-CoV-2 showed a superior plasma membrane fusion capacity compared to that of SARS-CoV. We solved the X-ray crystal structure of six-helical bundle (6-HB) core of the HR1 and HR2 domains in the SARS-CoV-2 S protein S2 subunit, revealing that several mutated amino acid residues in the HR1 domain may be associated with enhanced interactions with the HR2 domain. We previously developed a pan-coronavirus fusion inhibitor, EK1, which targeted the HR1 domain and could inhibit infection by divergent human coronaviruses tested, including SARS-CoV and MERS-CoV. Here we generated a series of lipopeptides derived from EK1 and found that EK1C4 was the most potent fusion inhibitor against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection with IC50s of 1.3 and 15.8\u2009nM, about 241- and 149-fold more potent than the original EK1 peptide, respectively. EK1C4 was also highly effective against membrane fusion and infection of other human coronavirus pseudoviruses tested, including SARS-CoV and MERS-CoV, as well as SARSr-CoVs, and potently inhibited the replication of 5 live human coronaviruses examined, including SARS-CoV-2. Intranasal application of EK1C4 before or after challenge with HCoV-OC43 protected mice from infection, suggesting that EK1C4 could be used for prevention and treatment of infection by the currently circulating SARS-CoV-2 and other emerging SARSr-CoVs.<\/jats:p>","DOI":"10.1038\/s41422-020-0305-x","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T12:04:10Z","timestamp":1585569850000},"page":"343-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1240,"title":["Inhibition of SARS-CoV-2 (previously 2019-nCoV)\u00a0infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion"],"prefix":"10.1038","volume":"30","author":[{"given":"Shuai","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-3542","authenticated-orcid":false,"given":"Qiaoshuai","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siliang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-5144","authenticated-orcid":false,"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-0391","authenticated-orcid":false,"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"305_CR1","unstructured":"WHO. Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. http:\/\/www.who.int\/medicines\/ebola-treatment\/WHO-list-of-top-emerging-diseases\/en\/ (2015)."},{"key":"305_CR2","unstructured":"WHO. Prioritizing diseases for research and development in emergency contexts. https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts (2019)."},{"key":"305_CR3","unstructured":"WHO. Coronavirus disease (accessed 23 February 2020). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel Coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"305_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"305_CR7","doi-asserted-by":"publisher","unstructured":"Gorbalenya, A. E. et al. The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-020-0695-z (2020).","DOI":"10.1038\/s41564-020-0695-z"},{"key":"305_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/22221751.2020.1723441","volume":"9","author":"S Jiang","year":"2020","unstructured":"Jiang, S., Du, L. & Shi, Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg. Microbes. Infect. 9, 275\u2013277 (2020).","journal-title":"Emerg. Microbes. Infect."},{"key":"305_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"305_CR10","doi-asserted-by":"publisher","unstructured":"Jiang, S. et al. A distinct name is needed for the new coronavirus. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30419-0 (2020).","DOI":"10.1016\/S0140-6736(20)30419-0"},{"key":"305_CR11","unstructured":"WHO. Coronavirus disease 2019 (COVID-19) situation report-32 (accessed 21 February 2020). https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200221-sitrep-32-covid-19.pdf?sfvrsn=4802d089_2."},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"305_CR13","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1073\/pnas.0400576101","volume":"101","author":"BJ Bosch","year":"2004","unstructured":"Bosch, B. J. et al. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. USA 101, 8455\u20138460 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","volume":"5","author":"S Xia","year":"2019","unstructured":"Xia, S. et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv. 5, eaav4580 (2019).","journal-title":"Sci. Adv."},{"key":"305_CR15","doi-asserted-by":"publisher","unstructured":"Xia, S. et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol. Immunol. https:\/\/doi.org\/10.1038\/s41423-020-0374-2 (2020).","DOI":"10.1038\/s41423-020-0374-2"},{"key":"305_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4067","volume":"5","author":"L Lu","year":"2014","unstructured":"Lu, L. et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 5, 3067 (2014).","journal-title":"Nat. Commun."},{"key":"305_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","volume":"363","author":"S Liu","year":"2004","unstructured":"Liu, S. et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363, 938\u2013947 (2004).","journal-title":"Lancet"},{"key":"305_CR18","doi-asserted-by":"crossref","unstructured":"Chong, H. et al. A lipopeptide HIV-1\/2 fusion inhibitor with highly potent in vitro, ex vivo, and in vivo antiviral activity. J. Virol. 91(2017).","DOI":"10.1128\/JVI.00288-17"},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/infdis\/jiy152","volume":"218","author":"C Mathieu","year":"2018","unstructured":"Mathieu, C. et al. Fusion inhibitory lipopeptides engineered for prophylaxis of Nipah virus in primates. J. Infect. Dis. 218, 218\u2013227 (2018).","journal-title":"J. Infect. Dis."},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","volume":"325","author":"RJ Garten","year":"2009","unstructured":"Garten, R. J. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197\u2013201 (2009).","journal-title":"Science"},{"key":"305_CR21","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1056\/NEJMe1212300","volume":"367","author":"LJ Anderson","year":"2012","unstructured":"Anderson, L. J. & Baric, R. S. Emerging human coronaviruses-disease potential and preparedness. N. Engl. J. Med. 367, 1850\u20131852 (2012).","journal-title":"N. Engl. J. Med."},{"key":"305_CR22","volume":"1","author":"CR Howard","year":"2012","unstructured":"Howard, C. R. & Fletcher, N. F. Emerging virus diseases: can we ever expect the unexpected? Emerg. Microbes. Infect. 1, e46 (2012).","journal-title":"Emerg. Microbes. Infect."},{"key":"305_CR23","first-page":"e01387","volume":"91","author":"K Shirato","year":"2016","unstructured":"Shirato, K., Kanou, K., Kawase, M. & Matsuyama, S. Clinical isolates of human coronavirus 229E bypass the endosome for cell entry. J. Virol 91,\u00a0e01387\u201316 (2016).","journal-title":"J. Virol"},{"key":"305_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virol.2017.11.012","volume":"517","author":"K Shirato","year":"2018","unstructured":"Shirato, K., Kawase, M. & Matsuyama, S. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. Virology 517, 9\u201315 (2018).","journal-title":"Virology"},{"key":"305_CR25","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","volume":"106","author":"S Belouzard","year":"2009","unstructured":"Belouzard, S., Chu, V. C. & Whittaker, G. R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. USA 106, 5871\u20135876 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"305_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.virol.2006.02.003","volume":"350","author":"KE Follis","year":"2006","unstructured":"Follis, K. E., York, J. & Nunberg, J. H. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell\u2013cell fusion but does not affect virion entry. Virology 350, 358\u2013369 (2006).","journal-title":"Virology"},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2020.03.025","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 1\u201310 (2020).","journal-title":"Cell"},{"key":"305_CR28","doi-asserted-by":"publisher","first-page":"e60302","DOI":"10.1371\/journal.pone.0060302","volume":"8","author":"A Hollmann","year":"2013","unstructured":"Hollmann, A. et al. Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action. PLoS ONE 8, e60302 (2013).","journal-title":"PLoS ONE"},{"key":"305_CR29","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/infdis\/jiv325","volume":"212","author":"R Channappanavar","year":"2015","unstructured":"Channappanavar, R. et al. Protective effect of intranasal regimens containing peptidic Middle East Respiratory Syndrome coronavirus fusion inhibitor against MERS-CoV infection. J. Infect. Dis. 212, 1894\u20131903 (2015).","journal-title":"J. Infect. Dis."},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0042-6822(03)00323-4","volume":"315","author":"H Jacomy","year":"2003","unstructured":"Jacomy, H. & Talbot, P. J. Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology 315, 20\u201333 (2003).","journal-title":"Virology"},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","journal-title":"Cell Res"},{"key":"305_CR32","doi-asserted-by":"publisher","unstructured":"Tang, X. L. et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci. Rev. https:\/\/doi.org\/10.1093\/nsr\/nwaa036 (2020).","DOI":"10.1093\/nsr\/nwaa036"},{"key":"305_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/v11010056","volume":"11","author":"S Xia","year":"2019","unstructured":"Xia, S. et al. Potent MERS-CoV fusion inhibitory peptides identified from HR2 domain in spike protein of bat coronavirus HKU4. Viruses 11, 56 (2019).","journal-title":"Viruses"},{"key":"305_CR34","doi-asserted-by":"crossref","unstructured":"Xia, S. et al. Peptide-Based membrane fusion inhibitors targeting HCoV-229E spike protein HR1 and HR2 domains. Int. J. Mol. Sci. 19 (2018).","DOI":"10.3390\/ijms19020487"},{"key":"305_CR35","doi-asserted-by":"crossref","unstructured":"Chen, Y. H. et al. Determination of the helix and beta form of proteins in aqueous solution 676 by circular dichroism. Biochemistry 13, 3350\u20133359 (1974)","DOI":"10.1021\/bi00713a027"},{"key":"305_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","volume":"67","author":"TG Battye","year":"2011","unstructured":"Battye, T. G. et al. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D. Biol. Crystallogr. 67, 271\u2013281 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"305_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"305_CR38","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1107\/S0907444904023510","volume":"60","author":"AA Vagin","year":"2004","unstructured":"Vagin, A. A. et al. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D. Biol. Crystallogr. 60, 2184\u20132195 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"305_CR39","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"305_CR40","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41422-020-0305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41422-020-0305-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41422-020-0305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:19:23Z","timestamp":1684603163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41422-020-0305-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1038\/s41422-020-0305-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.09.983247","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.737652439.793574774","asserted-by":"object"}]},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}